| Tregs: where we are and what comes next? H Zhao, X Liao, Y Kang Frontiers in immunology 8, 1578, 2017 | 206 | 2017 |
| Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity CA von Roemeling, Y Wang, Y Qie, H Yuan, H Zhao, X Liu, Z Yang, ... Nature communications 11 (1), 1508, 2020 | 179 | 2020 |
| Nanotechnology platforms for cancer immunotherapy Z Yang, Y Ma, H Zhao, Y Yuan, BYS Kim Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 12 (2 …, 2020 | 107 | 2020 |
| What else can CD39 tell us? H Zhao, C Bo, Y Kang, H Li Frontiers in immunology 8, 727, 2017 | 104 | 2017 |
| Therapeutic remodeling of the tumor microenvironment enhances nanoparticle delivery Y Chen, X Liu, H Yuan, Z Yang, CA von Roemeling, Y Qie, H Zhao, ... Advanced Science 6 (5), 1802070, 2019 | 93 | 2019 |
| Comparison of osteogenic differentiation capacity in mesenchymal stem cells derived from human amniotic membrane (AM), umbilical cord (UC), chorionic membrane (CM), and decidua … C Shen, C Yang, S Xu, H Zhao Cell & bioscience 9, 1-11, 2019 | 82 | 2019 |
| CD47: the next checkpoint target for cancer immunotherapy R Feng, H Zhao, J Xu, C Shen Critical reviews in oncology/hematology 152, 103014, 2020 | 69 | 2020 |
| Immunological conversion of solid tumours using a bispecific nanobioconjugate for cancer immunotherapy Y Lu, K Huntoon, DY Lee, Y Wang, JH Ha, Y Qie, X Li, BR Schrank, ... Nature nanotechnology 17 (12), 1332-1341, 2022 | 29 | 2022 |
| CD47 as a promising therapeutic target in oncology H Zhao, S Song, J Ma, Z Yan, H Xie, Y Feng, S Che Frontiers in Immunology 13, 757480, 2022 | 29 | 2022 |
| Thymosin α1 suppresses migration and invasion of PD-L1 high-expressing non-small-cell lung cancer cells via inhibition of STAT3–MMP2 signaling C Bo, Q Wu, H Zhao, X Li, Q Zhou OncoTargets and therapy, 7255-7270, 2018 | 25 | 2018 |
| The expanding family of noncanonical regulatory cell subsets H Zhao, R Feng, A Peng, G Li, L Zhou Journal of leukocyte biology 106 (2), 369-383, 2019 | 8 | 2019 |
| Compared with conventional procedures, an intraoperative navigation system for ventriculoperitoneal shunting via the occipital horn improves outcomes in patients with hydrocephalus AJ Peng, M Yang, H Zhao, YK Wu, Y Zhao, LX Zhou British Journal of Neurosurgery 35 (3), 292-300, 2021 | 6 | 2021 |
| Case report: neonatal giant forehead hemangiopericytoma with a 5-year follow-up AJ Peng, LB Zhang, H Zhao, LX Zhou Medicine 98 (47), e17888, 2019 | 4 | 2019 |
| CAR-T cell therapy for hematological malignancies: History, status and promise C Wang, J Wang, S Che, H Zhao Heliyon 9 (11), 2023 | 3 | 2023 |
| Deciphering the link: ferroptosis and its role in glioma H Wang, Y Liu, S Che, X Li, D Tang, S Lv, H Zhao Frontiers in Immunology 15, 1346585, 2024 | 2 | 2024 |
| Current state of immune checkpoints therapy for glioblastoma H Wang, J Yang, X Li, H Zhao Heliyon, 2024 | 2 | 2024 |
| The role of CD47 in non-neoplastic diseases C Wang, Y Feng, D Patel, H Xie, Y Lv, H Zhao Heliyon, 2023 | 2 | 2023 |
| Cuproptosis: unveiling a new frontier in cancer biology and therapeutics Y Feng, Z Yang, J Wang, H Zhao Cell Communication and Signaling 22 (1), 249, 2024 | 1 | 2024 |
| Surprising magic of CD24 beyond cancer H Wang, P Shi, X Shi, Y Lv, H Xie, H Zhao Frontiers in Immunology 14, 1334922, 2024 | 1 | 2024 |
| Unveiling the intratumoral microbiota within cancer landscapes S Che, Z Yan, Y Feng, H Zhao Iscience, 2024 | | 2024 |
